Evaluation of the osteoconductivity of α-tricalcium phosphate, β-tricalcium phosphate, and hydroxyapatite combined with or without simvastatin in rat calvarial defect

Journal of Biomedical Materials Research - Part A

Volumn 98 A, Issue 4, 2011, Pages 488-498

  Rojbani, Hisham ^a   Nyan, Myat ^a   Ohya, Keiichi ^a   Kasugai, Shohei ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

tricalcium phosphate; degradation; osteoconductivity; simvastatin

Indexed keywords

BONE FORMATION; BONE REGENERATION; BONE SUBSTITUTES; CALVARIAL BONES; CALVARIAL DEFECTS; CHOLESTEROL SYNTHESIS; CONTROL GROUPS; DEGRADABILITY; MICRO CT; OSTEOCONDUCTIVE MATERIALS; OSTEOCONDUCTIVITY; SIMVASTATIN; TRI-CALCIUM PHOSPHATES; WISTAR RAT;

ANIMALS; APATITE; BONE; DEFECTS; DEGRADATION; HYDROXYAPATITE; RATS;

TRANSMISSION CONTROL PROTOCOL;

ALPHA TRICALCIUM PHOSPHATE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; HYDROXYAPATITE; SIMVASTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE PROSTHESIS; BONE REGENERATION; CONDUCTANCE; CONTROLLED STUDY; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCONDUCTIVITY; PROTEIN EXPRESSION; RAT; SKULL DEFECT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BIOCOMPATIBLE MATERIALS; BONE REGENERATION; BONE SUBSTITUTES; CALCIUM PHOSPHATES; DRUG CARRIERS; DURAPATITE; HUMANS; IMPLANTS, EXPERIMENTAL; MALE; MATERIALS TESTING; RATS; RATS, WISTAR; SIMVASTATIN; SKULL; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 80051469068     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33117     Document Type: Article

References (37)

1. John HD, Wenz B,. Histomorphometric analysis of natural bone mineral for maxillary sinus augmentation. Int J Oral Maxillofac Implants 2004; 19: 199-207. (Pubitemid 38561056)
2. Boyne PJ, James RA,. Grafting of the maxillary sinus floor with autogenous marrow and bone. J Oral Surg 1980; 38: 613-616. (Pubitemid 11234933)
3. Brugnami F, Caiazzo A, Leone C,. Local intraoral autologous bone harvesting for dental implant treatment: Alternative sources and criteria of choice. Keio J Med 2009; 58: 24-28.
4. Moy PK, Lundgren S, Holmes RE,. Maxillary sinus augmentation: Histomorphometric analysis of graft materials for maxillary sinus floor augmentation. J Oral Maxillofac Surg 1993; 51: 857-862. (Pubitemid 23237076)
5. Younger EM, Chapman MW,. Morbidity at bone graft donor sites. J Orthop Trauma 1989; 3: 192-195.
6. Yuan H, Yang Z, De Bruij JD, De Groot K, Zhang X,. Material-dependent bone induction by calcium phosphate ceramics: A 2.5-year study in dog. Biomaterials 2001; 22: 2617-2623. (Pubitemid 32727836)
7. Kasugai S,. Local application of statin for bone augmentation. Clin Calcium 2005; 15: 67-72.
8. Kasugai S, Fujisawa R, Waki Y, Miyamoto K, Ohya K,. Selective drug delivery system to bone: Small peptide (Asp)6 conjugation. J Bone Miner Res 2000; 15: 936-43. (Pubitemid 30233418)
9. Li F, Zhao X, Wu J,. Repair of bone defect with allograft demineralized bone containing basic fibroblast growth factor in rabbits. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2005; 19: 431-434.
10. Santos FA, Pochapski MT, Martins MC, Zenobio EG, Spolidoro LC, Marcantonio E,. Comparison of biomaterial implants in the dental socket: Histological analysis in dogs. Clin Implant Dent Relat Res 2010; 12: 18-25.
11. Smeets R, Grosjean MB, Jelitte G, Heiland M, Kasaj A, Riediger D, Yildirim M, Spiekermann H, Maciejewski O,. Hydroxyapatite bone substitute (Ostim) in sinus floor elevation. Maxillary sinus floor augmentation: Bone regeneration by means of a nanocrystalline in-phase hydroxyapatite (Ostim). Schweiz Monatsschr Zahnmed 2008; 118: 203-212.
12. Alcaide M, Serrano MC, Pagani R, Sanchez-Salcedo S, Vallet-Regi M, Portoles MT,. Biocompatibility markers for the study of interactions between osteoblasts and composite biomaterials. Biomaterials 2009; 30: 45-51.
13. Kihara H, Shiota M, Yamashita Y, Kasugai S,. Biodegradation process of alpha-TCP particles and new bone formation in a rabbit cranial defect model. J Biomed Mater Res B Appl Biomater 2006; 79: 284-291. (Pubitemid 44652053)
14. Yamaguchi K, Hirano T, Yoshida G, Iwasaki K,. Degradation-resistant character of synthetic hydroxyapatite blocks filled in bone defects. Biomaterials 1995; 16: 983-985.
15. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G,. Stimulation of bone formation in vitro and in rodents by statins. Science 1999; 286: 1946-1949. (Pubitemid 129515901)
16. Nyan M, Sato D, Oda M, Machida T, Kobayashi H, Nakamura T, Kasugai S,. Bone formation with the combination of simvastatin and calcium sulfate in critical-sized rat calvarial defect. J Pharmacol Sci 2007; 104: 384-386. (Pubitemid 47378426)
17. Giannoudis PV, Dinopoulos H, Tsiridis E,. Bone substitutes: An update. Injury 2005; 36 (Suppl 3): S20-S27.
18. Rueger JM,. Bone substitution materials. Current status and prospects. Orthopade 1998; 27: 72-79.
19. Baqain ZH, Anabtawi M, Karaky AA, Malkawi Z,. Morbidity from anterior iliac crest bone harvesting for secondary alveolar bone grafting: An outcome assessment study. J Oral Maxillofac Surg 2009; 67: 570-575.
20. Beirne JC, Barry HJ, Brady FA, Morris VB,. Donor site morbidity of the anterior iliac crest following cancellous bone harvest. Int J Oral Maxillofac Surg 1996; 25: 268-271. (Pubitemid 126327850)
21. Swan MC, Goodacre TEE,. Morbidity at the iliac crest donor site following bone grafting of the cleft alveolus. Br J Oral Maxillofac Surg 2006; 44: 129-133. (Pubitemid 43323684)
22. Yoshimine Y, Akamine A, Mukai M, Maeda K, Matsukura M, Kimura Y, Makishima T,. Biocompatibility of tetracalcium phosphate cement when used as a bone substitute. Biomaterials 1993; 14: 403-406. (Pubitemid 23164181)
23. Walsh WR, Vizesi F, Michael D, Auld J, Langdown A, Oliver R, Yu Y, Irie H, Bruce W,. Beta-TCP bone graft substitutes in a bilateral rabbit tibial defect model. Biomaterials 2008; 29: 266-271. (Pubitemid 350060984)
24. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G,. Stimulation of bone formation in vitro and in rodents by statins. Science 1999; 286: 1946-1949. (Pubitemid 129515901)
25. Stein D, Lee Y, Schmid MJ, Killpack B, Genrich MA, Narayana N, Marx DB, Cullen DM, Reinhardt RA,. Local simvastatin effects on mandibular bone growth and inflammation. J Periodontol 2005; 76: 1861-1870. (Pubitemid 41748975)
26. Nyan M, Miyahara T, Noritake K, Hao J, Rodriguez R, Kuroda S, Kasugai S,. Molecular and tissue responses in the healing of rat calvarial defects after local application of simvastatin combined with alpha tricalcium phosphate. J Biomed Mater Res B Appl Biomater 2010; 93: 65-73.
27. Boyne PJ, Salina S, Nakamura A, Audia F, Shabahang S,. Bone regeneration using rhBMP-2 induction in hemimandibulectomy type defects of elderly sub-human primates. Cell Tissue Bank 2006; 7: 1-10. (Pubitemid 43336768)
28. Duan Z, Zheng Q, Guo X, Li C, Wu B, Wu W,. Repair of rabbit femoral defects with a novel BMP2-derived oligopeptide P24. J Huazhong Univ Sci Technol Med Sci 2008; 28: 426-430.
29. Giannoudis PV,. Fracture healing and bone regeneration: Autologous bone grafting or BMPs? Injury 2009; 40: 1243-1244.
30. Nyan M, Sato D, Kihara H, Machida T, Ohya K, Kasugai S,. Effects of the combination with alpha-tricalcium phosphate and simvastatin on bone regeneration. Clin Oral Implants Res 2009; 20: 280-287.
31. Skoglund B, Aspenberg P,. Locally applied Simvastatin improves fracture healing in mice. BMC Musculoskelet Disord 2007; 8: 98.
32. Hatano H, Maruo A, Bolander ME, Sarkar G,. Statin stimulates bone morphogenetic protein-2, aggrecan, and type 2 collagen gene expression and proteoglycan synthesis in rat chondrocytes. J Orthop Sci 2003; 8: 842-848. (Pubitemid 38017674)
33. Sonobe M, Hattori K, Tomita N, Yoshikawa T, Aoki H, Takakura Y, Suguro T,. Stimulatory effects of statins on bone marrow-derived mesenchymal stem cells. Study of a new therapeutic agent for fracture. Biomed Mater Eng 2005; 15: 261-267. (Pubitemid 40991528)
34. Zhang H, Lin C-Y,. Simvastatin stimulates chondrogenic phenotype of intervertebral disc cells partially through BMP-2 pathway. Spine (Phila Pa 1976) 2008; 33: 525-531.
35. Zhang M, Li XP, Qiao Y, Nie SP, Ma CS,. Does treatment with statins have the potential of enhancing vascular calcification? Chin Med J (Engl) 2008; 121: 473-474. (Pubitemid 351565998)
36. Mankani MH, Kuznetsov SA, Fowler B, Kingman A, Robey PG,. In vivo bone formation by human bone marrow stromal cells: Effect of carrier particle size and shape. Biotechnol Bioeng 2001; 72: 96-107. (Pubitemid 32085898)
37. Sun JS, Tsuang YH, Chang WH, Li J, Liu HC, Lin FH,. Effect of hydroxyapatite particle size on myoblasts and fibroblasts. Biomaterials 1997; 18: 683-690. (Pubitemid 27267831)